Antifungal and immunoadjuvant properties of fluconazole in mice immunosuppressed with morphine

Chemotherapy

Volumn 43, Issue 3, 1997, Pages 198-203

  Francesco, Paolo Di ^a   Gaziano, Roberta ^a   Casalinuovo, Ida A ^a   Palamara, Anna T ^a   Favalli, Cartesio ^a,b   Garaci, Enrico ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Candida albicans; Fluconazole; Immunosuppression; Intracellular killing; Morphine; Polymorphonuclear leukocytes

Indexed keywords

FLUCONAZOLE; MORPHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDIASIS; CONTROLLED STUDY; DRUG EFFICACY; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL TIME;

ANIMALS; BACTERIAL INFECTIONS; CANDIDA ALBICANS; FLUCONAZOLE; IMMUNOCOMPROMISED HOST; MALE; MICE; MORPHINE; NARCOTICS; NEUTROPHILS; PHAGOCYTOSIS;

EID: 0030928905     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239561     Document Type: Article

References (23)

1. Rubin RH: Fungal and bacterial infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis 1993;1:42-48.
2. Gallis HA, Drew RH, Pickard WW: Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990; 12: 308-329.
3. Fazio RA, Wickremesinghe PC, Arsura EL: Ketoconazole treatment of Candida esophagitis: A prospective study of 12 cases. Am J Gastroenterol 1983;78:261-264.
4. Jordan WM, Bodey GP, Rodriguez V, Ketchel SJ, Henney J: Miconazole therapy for treatment of fungal infections in cancer patients. Anti-microb Agents Chemother 1979; 16: 792-797.
5. Yeates RA, Ruhnke M, Pfaff G, Hartmann A, Trautmann M, Sarnow E: The pharmacokineticsof fluconazole after a single intravenous dose in AIDS patients. Br J Clin Pharmacol 1994:38:77-79.
6. Sckhon AS, Padhye AA, Garg AK, Hamir Z: Effects of culture media on the in vitro susceptibility of selected opportunistic fungi to fluconazole and itraconazole. Chemotherapy 1992;38:169-173.
7. Grant SM, Clissold SP: Fluconazole: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 1990;39:877-916.
8. Di Francesco P, Casalinuovo I, Gaziano R, Marini S, Favalli C: In vivo but not in vitro activation of T cell response by fluconazole. Med Sci Res 1995:32:263-265.
9. Di Francesco P, Gaziano R, Casalinuovo I, Belogi L, Palamara AT, Favalli C, Garaci E: Combined effect of fluconazole and thymosin al on systemic candidiasis in mice immu-nosuppressed by morphine treatments. Clin Exp Immunol 1994:97: 347-352.
10. Bridges CG, Dasilava GL, Yama-mura M, Valdimarson H: A radiometric assay for the combined measurement of phagocytosis and intracellular killing of the C. albicans. Clin Exp Immunol 1980:42:226-233.
11. Di Francesco P, Pica F, Croce C, Favalli C, Tubaro E, Garaci E: Effect of acute or daily cocaine administration on cellular immune response and virus infection in mice. Nat Immun 1990;9:397-405.
12. Falchctti R, Di Francesco P, Lanzilli G, Gaziano R, Casalinuovo IA, Ravagnan G, Garaci E: In vitro effects of cocaine on cytokine secretion induced in murine splenic CD4* T cells by antigen-specific stimulation. Cell Immunol 1995; 164:57-64.
13. Carr DJJ, Serou M: Exogenous and endogenous opioids as biological response modifiers. Immunopharma-cology 1995;31:59-71.
14. Tubaro E, Borelli G, Croce C, Cavallo G, Santiangeli C: Effect of morphine on resistance to infection. J Infect Dis 1983;48:656-666.
15. Peterson PK, Sharp B, Gekker G, Brummit C, Keane WF: Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J Immunol 1987;138:3907-3915.
16. Pillai R, Nair BS, Watson RR: Aids, drugs of abuse and the immune system: A complex immunotoxicologi-cal network. Arch Toxicol 1991;65: 609-617.
17. Peterson PK, Molitor TW, Chao CC: Mechanism of morphine-induced immunomodulation Biochem Pharmacol 1993;46:343-348.
18. Bistoni F, Vccchiarclli A, Mazzolla R, Puccetti P, Marconi P, Garaci E: Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans. An-timicrob Agents Chemother 1985; 27:625-631.
19. Edhit M, Stuben A, Gorz A, Weller U, Bhakdi S: Novel aspect of amphotericin B action: Accumulation in human monocytes potentiates killing of phagocytosed Candida albicans. Antimicrob Agents Chemother 1994;38:13-22.
20. Richardson MD, Scott G, Shank-land GS: Effect of cylofungin on phagocytosis and intracellular killing of Candida albicans by human neutrophils. Eur J Clin Microbiol Infect Dis 1992; 11:22.
21. Steinbeck MJ, Roth JA: Neutrophil activation by recombinant cytokines. Rev Infect Dis 1989:11:549-568.
22. Stevenhagen A, van Furt R: Interferon gamma activates the oxidative killing of Candida albicans by human granulocytes. Clin Exp Immunol 1993;91:170-175.
23. Pascual A, Garcia I, Conejo C, Perea E: Uptake and intracellular activity of fluconazole in human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1993;37:187-190.